A small toilet-based sound sensor that can tell the difference between peeing, pooping and diarrhea may one day help prevent cholera outbreaks. “The hope is that this sensor, which is small in footprint and noninvasive in approach,...

Science reveals 3 key factors to an energized, alert day. What you eat, when you wake up and how active you are all matter, new research shows. Read more Banning flavored vapes didn’t get folks to quit....

Infants and young children could soon receive an updated COVID-19 vaccine as part of their three-dose series. Pfizer Inc. on Monday asked the U.S. Food and Drug Administration to have the vaccine that targets the Omicron subvariants...

American kids are drinking to excess less and abusing marijuana more, a new study finds. Marijuana abuse among 6- to 18-year-olds has increased 245% since 2000, while child alcohol abuse has steadily declined over those years, say...

Money may not buy happiness, but it might give low-income obese people an extra incentive to lose weight, a new study suggests. The study, of people from urban neighborhoods, found that cash rewards encouraged participants to shed...

Growing numbers of Americans are suffering prolonged, life-threatening seizures known as status epilepticus, and Black people are nearly twice as likely to experience these seizures as white people. These are the main findings from new research looking...

MONDAY, Dec. 5, 2022 (American Heart Association News) — Actor and musician Rob Benedict was in his natural habitat, onstage and entertaining an audience, when two of his friends decided to pull a practical joke on him....

People who’ve had a bout of shingles may face a heightened risk of heart attack or stroke in later years, a new, large study suggests. Anyone who ever had chickenpox can develop shingles — a painful rash...

Seizures tend to get progressively worse over time in people with epilepsy, and a new study in mice suggests why that might be the case. Seizures appear to prompt the brains of mice to produce more myelin,...

The last of six COVID monoclonal antibody treatments has lost its federal authorization because, like the others, it no longer works against the newest Omicron subvariants. This last monoclonal antibody was bebtelovimab, delivered as a one-hour IV...